Quantitative evaluation of inflammatory response dynamics in the lung following proton and photon irradiation
ORAL
Abstract
46 patients (23 SBPT/SBRT) were matched based on patient characteristics, quantitative assessment correlated highly with expert evaluation (p<10-13,rho=0.6). The maximum response averages 3.8±3.0 (SBPT) versus 3.2±2.4 HU/Gy (SBRT). The lung response after SBRT significantly increases over the observation period (p=0.003), but not after SBPT, indicating an accelerated acute response after SBPT.
We demonstrate that quantitative normal lung response evaluation correlates well with established grading systems and differences in response dynamics after SBPT compared to SBRT, that warrant further investigation into their mechanisms of inflammation.
–
Presenters
-
Yanjing Li
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
Authors
-
Yanjing Li
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
-
Micheal Dykstra
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
-
Till Best
Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School
-
Jennifer Pursley
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
-
Nitish Chopra
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
-
Harald Paganetti
Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, Massachusetts General Hospital, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
-
Henning Willers
Massachusetts General Hospital, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
-
Florian Fintelmann
Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School
-
Clemens Grassberger
Massachusetts General Hospital, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School